Rituximab en el manejo de miositis refractaria: a propósito de dos casos / Rituximab in the treatment of refractory myositis: on purpose of two cases
Rev. Soc. Peru. Med. Interna
; 23(3): 109-111, jul.-sept. 2010.
Article
em Es
| LILACS, LIPECS
| ID: lil-568280
Biblioteca responsável:
PE1.1
RESUMEN
Se presenta dos casos de miositis, uno con dermatomiositis y otro con polimiositis, que fueron refractarios al tratamiento con esteroides (prednisona y metilprednisolona) y citotóxicos (aziatropina y ciclofosfamida). Se administró rituximab y se obtuvo mejoría clínica y disminución de las actividades enzimáticas en las semanas siguientes.
ABSTRACT
It is showed two cases of miositis (one with dermatomyositis and another with polimyositis) that did not respond to treatment with steroids (prednisone and metylprednisolone) and cytotoxic drugs (azatioprine and cyclophosphamide). Rituximab was administered and a good clinical response and diminished enzymatic activities were obtained on the following weeks.
Buscar no Google
Coleções:
01-internacional
Base de dados:
LILACS
/
LIPECS
Assunto principal:
Esteroides
/
Azatioprina
/
Polimiosite
/
Ciclofosfamida
/
Dermatomiosite
/
Anticorpos Monoclonais
/
Miosite
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
Idioma:
Es
Ano de publicação:
2010
Tipo de documento:
Article